{"Title": ["BUZZ-U.S. STOCKS ON THE MOVE-Soliton Inc, Altimmune, Recon Technology", "BlackBerry Ltd (BBRY) Stock Needs More Than a Successful Lawsuit", "Mid-Day Market Update: Dow Drops Over 100 Points; Arena Pharmaceuticals Shares Plummet", "Mid-Morning Market Update: Markets Open Lower; Goldman Sachs Earnings Miss Estimates", "Mid-Afternoon Market Update: GNC Gains On Upbeat Earnings; Barracuda Shares Drop", "Midday Update: Market Averages Trade Higher as Bargain-Hunting Overshadows Geopolitical Risks", "Mid-Day Market Update: Dow Surges Over 100 Points; Oncomed Shares Slide", "Mid-Morning Market Update: Markets Open Higher; Ant Financial Increases Bid For Moneygram", "BUZZ-U.S. STOCKS ON THE MOVE-Soliton Inc, Altimmune, Recon Technology", "Mid-Afternoon Market Update: Crude Oil Down 1%; MOCON Shares Spike Higher", "Health Care Sector Update for 04/17/2017: TNXP,CBLI,OMED", "Health Care Sector Update for 03/16/2016: CBLI,ORPN,NSPR", "Cleveland BioLabs Gets Orphan Status for Entolimod in EU", "Health Care Sector Update for 12/22/2015: CBLI, PBMD", "Health Care Sector Update for 07/16/2015: CBLI,DNAI,DCTH", "Health Care Sector Update for 04/27/2015: NBS, CBLI, TRIL", "Health Care Sector Update for 04/17/2017: HTGM,CBLI,OMED", "Health Care Sector Update for 01/28/2015: CBLI,ABMD,AGIO", "Sector Update: Health Care Stock Turn Lower; Cleveland BioLabs Lights Up After FDA Approves Radiation Treatment", "Sector Update: Health Care", "Good News for Cleveland BioLabs - Analyst Blog", "Sector Update: Healthcare Stocks Lower; CBLI Slides 42% on Abandoned Development Plans", "Sector Update: Healthcare", "Healthcare Stocks Ending with Losses; Cleveland Labs Falls to Record Low After Partner Pulls Plug on Radiation Treatment", "Health Care Sector Update for 02/24/2015: CBLI, STJ, UTHR", "Sector Update: Healthcare Shares Flat to Higher; Cleveland BioLabs Cuts Net Loss in Half Year-Over-Year", "Sector Update: Healthcare", "Pre-Market Earnings Report for August 13, 2013 : VAL, FLO, AG, GENT, SCR, CACH, CBLI, PFSW, CIMT, ENSV", "Isis Initiates ISIS-STAT3 Study - Analyst Blog", "Gilead Misses on Earnings, Sales in 1Q - Analyst Blog", "Negative Opinion on AVEO/ALPMY Candidate - Analyst Blog", "Loss at Aegerion Narrower Than Expected - Analyst Blog", "Sector Update: Healthcare", "Vertex Loss Lower, Kalydeco Outlook Up - Analyst Blog", "Merck - Pfizer in Diabetes Deal - Analyst Blog", "Double Setback for Gilead - Analyst Blog", "Geron Narrows Loss; Cuts Jobs - Analyst Blog", "CHMP in Favor of Celgene's Revlimid - Analyst Blog", "Earnings Increase at The Medicines Co. - Analyst Blog", "Biogen's Earnings Surpass Expectations - Analyst Blog", "Affymetrix Reports Disappointing 1Q - Analyst Blog", "Isis Pharma's ISIS-SMNRx Progresses - Analyst Blog", "Merck - BMY in HCV Deal - Analyst Blog", "Merck In-Licenses from Xenon - Analyst Blog", "Achillion's HCV Candidates Progress - Analyst Blog", "Actelion Beats Earnings, Sales Rise - Analyst Blog", "Repros Gets Additional Patents - Analyst Blog", "Alkermes Announces Restructuring Plan - Analyst Blog", "Tax Benefit Boosts Amgen Earnings - Analyst Blog", "ADC Data from Seattle Genetics - Analyst Blog", "Illumina Introduces TruSight Tumor - Analyst Blog", "Positive Data on Repros' Androxal - Analyst Blog", "Zacks Rank #1 Additions for Thursday - Tale of the Tape", "Affymetrix Inks Deal with UK Biobank - Analyst Blog", "Zacks #1 Rank Additions for Thursday - Tale of the Tape", "Stem Cell Therapy May Prevent Heart Failure: 4 Companies to Watch", "Affymetrix to Disappoint in 1Q - Analyst Blog", "4 Stocks That Could Plummet in the Weeks Ahead"], "Elapsed Time": ["18 HOURS AGO", "APR 20, 2017", "APR 18, 2017", "APR 18, 2017", "APR 18, 2017", "APR 17, 2017", "APR 17, 2017", "APR 17, 2017", "18 HOURS AGO", "APR 17, 2017", "APR 17, 2017", "MAR 16, 2016", "JAN 22, 2016", "DEC 22, 2015", "JUL 16, 2015", "APR 27, 2015", "APR 17, 2017", "JAN 28, 2015", "SEP 3, 2014", "SEP 3, 2014", "APR 17, 2014", "JAN 23, 2014", "JAN 23, 2014", "JAN 23, 2014", "FEB 24, 2015", "AUG 13, 2013", "AUG 13, 2013", "AUG 12, 2013", "MAY 7, 2013", "MAY 3, 2013", "MAY 3, 2013", "MAY 3, 2013", "JAN 23, 2014", "MAY 1, 2013", "APR 30, 2013", "APR 30, 2013", "APR 29, 2013", "APR 29, 2013", "APR 26, 2013", "APR 25, 2013", "MAY 2, 2013", "APR 24, 2013", "APR 23, 2013", "APR 22, 2013", "APR 17, 2013", "APR 16, 2013", "APR 12, 2013", "APR 11, 2013", "APR 24, 2013", "APR 10, 2013", "APR 8, 2013", "APR 4, 2013", "MAR 28, 2013", "MAR 28, 2013", "MAR 21, 2013", "NOV 16, 2011", "APR 10, 2013", "OCT 26, 2010"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-soliton-inc-altimmune-recon-technology-2020-06-26", "https://www.nasdaq.com/articles/blackberry-ltd-bbry-stock-needs-more-than-a-successful-lawsuit-2017-04-20", "https://www.nasdaq.com/articles/mid-day-market-update-dow-drops-over-100-points-arena-pharmaceuticals-shares-plummet-2017", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-goldman-sachs-earnings-miss-estimates-2017-04", "https://www.nasdaq.com/articles/mid-afternoon-market-update-gnc-gains-upbeat-earnings-barracuda-shares-drop-2017-04-18", "https://www.nasdaq.com/articles/midday-update-market-averages-trade-higher-bargain-hunting-overshadows-geopolitical-risks", "https://www.nasdaq.com/articles/mid-day-market-update-dow-surges-over-100-points-oncomed-shares-slide-2017-04-17", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-ant-financial-increases-bid-moneygram-2017", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-soliton-inc-altimmune-recon-technology-2020-06-26", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-down-1-mocon-shares-spike-higher-2017-04-17", "https://www.nasdaq.com/articles/health-care-sector-update-04172017-tnxpcbliomed-2017-04-17", "https://www.nasdaq.com/articles/health-care-sector-update-03162016-cbliorpnnspr-2016-03-16", "https://www.nasdaq.com/articles/cleveland-biolabs-gets-orphan-status-for-entolimod-in-eu-2016-01-22", "https://www.nasdaq.com/articles/health-care-sector-update-12222015-cbli-pbmd-2015-12-22", "https://www.nasdaq.com/articles/health-care-sector-update-07162015-cblidnaidcth-2015-07-16", "https://www.nasdaq.com/articles/health-care-sector-update-04272015-nbs-cbli-tril-2015-04-27", "https://www.nasdaq.com/articles/health-care-sector-update-04172017-htgmcbliomed-2017-04-17", "https://www.nasdaq.com/articles/health-care-sector-update-01282015-cbliabmdagio-2015-01-28", "https://www.nasdaq.com/articles/sector-update-health-care-stock-turn-lower-cleveland-biolabs-lights-after-fda-approves", "https://www.nasdaq.com/articles/sector-update-health-care-2014-09-03-0", "https://www.nasdaq.com/articles/good-news-for-cleveland-biolabs-analyst-blog-2014-04-17", "https://www.nasdaq.com/articles/sector-update-healthcare-stocks-lower-cbli-slides-42-abandoned-development-plans-2014-01", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-01-23-0", "https://www.nasdaq.com/articles/healthcare-stocks-ending-losses-cleveland-labs-falls-record-low-after-partner-pulls-plug", "https://www.nasdaq.com/articles/health-care-sector-update-02242015-cbli-stj-uthr-2015-02-24", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-higher-cleveland-biolabs-cuts-net-loss-half-year-over", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-08-13-0", "https://www.nasdaq.com/articles/pre-market-earnings-report-august-13-2013-val-flo-ag-gent-scr-cach-cbli-pfsw-cimt-ensv", "https://www.nasdaq.com/articles/isis-initiates-isis-stat3-study-analyst-blog-2013-05-07", "https://www.nasdaq.com/articles/gilead-misses-on-earnings-sales-in-1q-analyst-blog-2013-05-03", "https://www.nasdaq.com/articles/negative-opinion-on-aveo-alpmy-candidate-analyst-blog-2013-05-03", "https://www.nasdaq.com/articles/loss-at-aegerion-narrower-than-expected-analyst-blog-2013-05-03", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-01-23", "https://www.nasdaq.com/articles/vertex-loss-lower-kalydeco-outlook-up-analyst-blog-2013-05-01", "https://www.nasdaq.com/articles/merck-pfizer-in-diabetes-deal-analyst-blog-2013-04-30", "https://www.nasdaq.com/articles/double-setback-for-gilead-analyst-blog-2013-04-30", "https://www.nasdaq.com/articles/geron-narrows-loss-cuts-jobs-analyst-blog-2013-04-29", "https://www.nasdaq.com/articles/chmp-in-favor-of-celgenes-revlimid-analyst-blog-2013-04-29", "https://www.nasdaq.com/articles/earnings-increase-at-the-medicines-co.-analyst-blog-2013-04-26", "https://www.nasdaq.com/articles/biogens-earnings-surpass-expectations-analyst-blog-2013-04-25", "https://www.nasdaq.com/articles/affymetrix-reports-disappointing-1q-analyst-blog-2013-05-02", "https://www.nasdaq.com/articles/isis-pharmas-isis-smnrx-progresses-analyst-blog-2013-04-24", "https://www.nasdaq.com/articles/merck-bmy-in-hcv-deal-analyst-blog-2013-04-23", "https://www.nasdaq.com/articles/merck-in-licenses-from-xenon-analyst-blog-2013-04-22", "https://www.nasdaq.com/articles/achillions-hcv-candidates-progress-analyst-blog-2013-04-17", "https://www.nasdaq.com/articles/actelion-beats-earnings-sales-rise-analyst-blog-2013-04-16", "https://www.nasdaq.com/articles/repros-gets-additional-patents-analyst-blog-2013-04-12", "https://www.nasdaq.com/articles/alkermes-announces-restructuring-plan-analyst-blog-2013-04-11", "https://www.nasdaq.com/articles/tax-benefit-boosts-amgen-earnings-analyst-blog-2013-04-24", "https://www.nasdaq.com/articles/adc-data-from-seattle-genetics-analyst-blog-2013-04-10", "https://www.nasdaq.com/articles/illumina-introduces-trusight-tumor-analyst-blog-2013-04-08", "https://www.nasdaq.com/articles/positive-data-on-repros-androxal-analyst-blog-2013-04-04", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-thursday-tale-of-the-tape-2013-03-28", "https://www.nasdaq.com/articles/affymetrix-inks-deal-with-uk-biobank-analyst-blog-2013-03-28", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-thursday-tale-of-the-tape-2013-03-21", "https://www.nasdaq.com/articles/stem-cell-therapy-may-prevent-heart-failure-4-companies-watch-2011-11-16", "https://www.nasdaq.com/articles/affymetrix-to-disappoint-in-1q-analyst-blog-2013-04-10", "https://www.nasdaq.com/articles/4-stocks-could-plummet-weeks-ahead-2010-10-26"], "Content": []}